Ready to accelerate your clinical trial? Visit bioaccess® →
Global Trial Accelerators™
Global Trial Accelerators™
Accelerate Your Path from First-in-Human to Exit Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is the only podcast for healthcare startup founders and innovators navigating first-in-human (FIH) clinical trials. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark. bioaccess® is a CRO purpose-built for first-in-human (FIH) trials — serving MedTech, Biopharma, and Radiopharma startups. This podcast delivers strategies, regulatory insights, and founder stories to get your technology into humans faster and affordably, with data designed to support FDA and EMA submissions. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and founders who've compressed timelines, reduced costs, and generated the clinical evidence investors demand — by leveraging Latin America's clinical research infrastructure. What You'll Learn: - Regulatory pathways across 10+ Latin American countries (Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, Paraguay) - Why ethics approval in 4-8 weeks (vs. 6-12 months in US/EU) changes the game for startups - Strategies to generate FIH data that unlocks your next funding round or acquisition - The Innovation Runway: from prototype to clinical milestones before capital runs out - Case studies from 58+ companies — seed-stage startups to Fortune 500 MedTech - Decentralized trials, AI-driven recruitment, and post-trial commercialization "bioaccess® compressed our timeline by 9 months vs. our US plan. This podcast is why we partnered with them." – Digital Health Startup CEO New episodes weekly. Subscribe to unlock your shortcut from first-in-human to exit. Brought to you by bioaccess® — an FIH-dedicated CRO for healthcare startups. Faster timelines, lower costs. Since 2010.
Choose your favorite podcast player
Apple Podcasts Spotify
RSS Feed
32,000+ LinkedIn followers

The clinical trials podcast for healthcare startups: your roadmap from first-in-human to exit.

90% of healthcare startups fail — not because the technology fails, but because they run out of capital before generating the clinical data investors need. Global Trial Accelerators™ is the clinical trials podcast from bioaccess®, a CRO built exclusively for first-in-human (FIH) trials. Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), produced by bioaccess®, and founded by Co-Founder & CEO Julio G. Martinez-Clark.

Apple Podcasts podcast player icon Apple Podcasts Apple Podcasts Spotify podcast player icon Spotify Spotify
RSS Feed

90% of healthcare startups fail not because their technology doesn’t work, but because they run out of capital before generating the clinical data investors need to see. Global Trial Accelerators™ is the clinical trials podcast from bioaccess® — a CRO purpose-built exclusively for first-in-human (FIH) trials — built to help you solve that problem faster, smarter, and at lower cost.

Every episode delivers practical strategies from startup founders, CRO executives, regulatory experts, and healthcare investors. Topics include regulatory pathways across 19 Latin American countries, ethics approval timelines (4–8 weeks vs. 6–12 months in US/EU), FIH trial design for MedTech, Biopharma, and Radiopharma, patient recruitment strategies with treatment-naïve cohorts, and how to generate the clinical milestones that unlock funding rounds and strategic acquisitions.

This podcast is designed for MedTech, Biopharma, and Radiopharma startup founders, regulatory affairs professionals, clinical operations managers, and healthcare investors looking for a competitive edge. Whether you’re preparing for your first FIH trial, a mid-stage company seeking faster clinical pathways, or an investor evaluating clinical-stage opportunities, Global Trial Accelerators™ gives you the insider knowledge you need to move faster and make smarter decisions.

New episodes are published weekly, featuring expert interviews, regulatory deep dives, and practical strategy sessions covering FIH clinical trials across Latin America.

Can clinical trials in Latin America really be faster and more affordable?

Yes. Many countries in Latin America offer streamlined ethics committee approvals that can be completed in 4 to 8 weeks compared to 6–12 months in the US or EU. Combined with lower operational costs, startups can reduce overall trial budgets while maintaining full FDA and EMA compliance.

What types of clinical trials does this podcast cover?

The podcast focuses on first-in-human clinical trials across MedTech (medical devices, diagnostics, digital health), Biopharma (novel therapeutics, biologics, biosimilars), and Radiopharma (radiopharmaceuticals, nuclear medicine). We also explore decentralized trials, AI-driven diagnostics, and theranostics.

Who are the hosts of Global Trial Accelerators™?

The podcast is hosted by Julio G. Martinez-Clark, Co-Founder & CEO of bioaccess®, and Jesús E. Moreno, Business Development Director at bioaccess®. Together they bring over a decade of experience helping MedTech, Biopharma, and Radiopharma startups accelerate first-in-human clinical trials across Latin America.

Recent

Deborah Morley, Director CV Strategy and Delivery at RQM+
Aug. 28, 2026

Deborah Morley, Director CV Strategy and Delivery at RQM+

In this episode, we speak with Deborah Morley, a leading expert in cardiovascular innovation and medical device development. With a PhD in Cardiovascular Physiology and extensive experience across academia, clinical research, regulatory strategy, and industry, Deborah has played a key role in advancing Class III implantable cardiovascular devices, including LVADs and cardiac contractility modulation systems. Today, she serves as Director, Cardiovascular Strategy and Delivery and Co-Leader of th
Watch the Video
Deborah Morley, Director CV Strategy and Delivery at RQM+
135
Aug. 27, 2026

Deborah Morley, Director CV Strategy and Delivery at RQM+

In this episode, we speak with Deborah Morley, an experienced leader in cardiovascular innovation, clinical research, and medical device development. Her career spans academia and industry, with extensive expertise in regulatory strategy and Class III implantable cardiovascular devices, including LVADs and cardiac contractility modulation systems. She currently serves as Director, Cardiovascular Strategy and Delivery and Co-Leader of the Cardiovascular Center of Excellence at RQM+.
Listen to the Episode
Leonara Vidal, Global Clinical Affairs Lead at Gentell
Aug. 21, 2026

Leonara Vidal, Global Clinical Affairs Lead at Gentell

In this episode, we sit down with Leonara Vidal, Global Clinical Affairs Lead at Gentell, to explore her international journey in clinical research, healthcare innovation, and medical devices. From her early work as a nurse and professor in Brazil to collaborating with Johns Hopkins University and USAID, Leonara has built a remarkable career across Europe and the UK. We discuss clinical research, medical innovation, patient outcomes, leadership, and the future of healthcare, as well as her exp
Watch the Video
Leonara vidal, Global Clinical Affairs Lead at Gentell
134
Aug. 21, 2026

Leonara vidal, Global Clinical Affairs Lead at Gentell

In this episode, we speak with Leonara Vidal, Global Clinical Affairs Lead at Gentell, about her international career in clinical research, healthcare innovation, and medical devices. Leonara shares her journey from nursing and academia in Brazil to leading global clinical affairs initiatives across Europe and the UK, offering insights into clinical evidence, innovation, leadership, and improving patient outcomes.
Listen to the Episode
Gerardo Noriega, Presiden & CEO at PercAssist, Inc
Aug. 6, 2026

Gerardo Noriega, Presiden & CEO at PercAssist, Inc

In this episode, we sit down with Gerardo Noriega, a C-level executive, serial entrepreneur, inventor, and scholar with decades of experience in the global medical device industry. Gerardo has founded five medical device companies and has advised more than 50 medical technology startups and established companies across Silicon Valley. Throughout his career, he has specialized in identifying unmet clinical needs, transforming breakthrough ideas into protected intellectual property, and leading i
Watch the Video
Gerardo Noriega, Presiden & CEO at PercAssist, Inc
133
Aug. 6, 2026

Gerardo Noriega, Presiden & CEO at PercAssist, Inc

Today's guest is Gerardo Noriega, a C-level executive, serial entrepreneur, inventor, and advisor in the medical device industry. Having founded five medical device companies and consulted for more than 50 organizations throughout Silicon Valley, Gerardo has spent his career identifying unmet clinical needs, developing innovative technologies, and guiding products from early-stage concepts to successful commercialization. He also serves on the advisory boards of Santa Clara University's Depar...
Listen to the Episode
View all Episodes View all Videos

Recent Blog Posts

The Undeniable Link: Patient Experience and Practice Growth
June 9, 2026

The Undeniable Link: Patient Experience and Practice Growth

Welcome back to the blog, fellow podcast enthusiasts! Today, we're diving deep into a topic that resonated profoundly in our latest episode, Shareef Mahdavi, Founder at PX Movement. In that conversation, Shareef shared a message that, while seemingl…
Read the Blog Post
From Startup to Scale-Up: Navigating Regulatory Challenges in the Medical Device Industry
April 9, 2026

From Startup to Scale-Up: Navigating Regulatory Challenges in the Medical Device Industry

Introduction: The MedTech Rollercoaster - From Startup Dreams to Scale-Up Realities The journey from a groundbreaking idea for a medical device to a product that actually reaches patients is, to put it mildly, a rollercoaster. For startups in the M…
Read the Blog Post
Accelerating Medical Device Approvals: Strategies from a Regulatory Expert
March 26, 2026

Accelerating Medical Device Approvals: Strategies from a Regulatory Expert

Welcome back to the blog, and to an episode that’s been buzzing with invaluable insights for anyone venturing into the complex world of medical device innovation! In our latest podcast installment, we had the distinct pleasure of speaking with Krist…
Read the Blog Post
View all posts

About the Hosts

Julio G Martinez-Clark Profile Photo
Julio G Martinez-Clark

CEO, bioaccess®

Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech, Biopharma, and Radiopharma innovation by positioning Latin America as a global leader in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.

Jesus E. Moreno Profile Photo
Jesus E. Moreno

Business Development Director, bioaccess®

Jesus E. Moreno is a business development director who provides efficient and reliable clinical research services in Latin America. With a passion for driving innovation in the healthcare sector, Jesus leverages his bilingual biomedical engineering background and his understanding of the unique challenges that Medtech startups face to provide valuable support and deliver accelerated clinical study results. Jesus profoundly understands the critical role that reliable and streamlined clinical research plays in the success of Medtech startups. He firmly believes that by offering cost-effective solutions without compromising quality, Medtech startups can achieve their clinical goals faster and make a meaningful impact in the healthcare industry. Jesus is passionate about supporting Medtech startups in their journey towards bringing innovative medical technologies to market. Jesus possesses the technical expertise to understand the complexities of medical devices and technologies. This knowledge enables him to identify tailored solutions that meet the specific needs of Medtech startups. Jesus has a bachelor's degree in biomedical engineering and a master's degree in electronics engineering.